Evidence map›Paper›PMID 39918005›Full record

ArticleMolecular imaging and radionuclide therapy2025

Impact of

Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, Emre Demirci, Ayşegül Görmez, Bala Başak Öven, Serkan Çelik, Fatma Şen, Özge Kapar, Levent Kabasakal

Abstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Same-day dual-tracer PET/CT imaging with [Annals of nuclear medicine · 2025
    Trial
  2. Review
  3. Preoperative [Frontiers in immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nalan Alan SelçukYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-3738-6491
Gamze BeydağıYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0001-7187-7203
Kaan AkçayYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-7706-6388
Emre DemirciUniversity of Missouri Faculty of Medicine, Department of Radiology, Missouri, USA.ORCID 0000-0002-6387-9089
Ayşegül GörmezYeditepe University Faculty of Medicine, Department of Radiology İstanbul, Türkiye.ORCID 0000-0001-5620-2881
Bala Başak ÖvenYeditepe University Faculty of Medicine, Department of Medical Oncology, İstanbul, Türkiye.ORCID 0000-0002-9921-4089
Serkan ÇelikYeditepe University Faculty of Medicine, Department of Medical Oncology, İstanbul, Türkiye.ORCID 0000-0002-5124-6823
Fatma ŞenAvrasya Hospital, Clinic of Medical Oncology, İstanbul, Türkiye.ORCID 0009-0003-9026-886X
Özge KaparGöztepe Prof. Dr. Süleyman Yalçın City Hospital, Clinic of Pathology, İstanbul, Türkiye.ORCID 0000-0001-6751-758X
Levent Kabasakalİstanbul University-Cerrahpasa, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-4050-1972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to evaluate the potential efficacy of Methods: We conducted a prospective analysis of 30 patients with pathologically confirmed primary tumors or metastases of the digestive system. Participants underwent Results: Conclusion: Based on our study,

Indexed as

68Ga-FAPi PET/CT imaginggastrointestinal malignanciestumor microenvironment

Identifiers

PMID39918005
PMCPMC11827526

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.